Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Icatibant for ACE-I-Induced Angioedema
NCT01919801Phase 3Completed
- Sponsor
- Takeda
- Start
- Dec 2013
- Primary completion
- Aug 2015
- Modality
- Peptides, Small Molecules
- Countries
- 4
01
Overview
A Phase 3 trial of icatibant in ACE-inhibitor induced angioedema (ACEI-AAG), sponsored by Takeda. Started Dec 2013; status: completed.
02
Drugs
icatibant
03
Conditions
ACE-inhibitor induced angioedema (ACEI-AAG)
Beyond the preview
Go deeper on NCT01919801.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT01919801.